HC Wainwright Reaffirms “Buy” Rating for Pharming Group (NASDAQ:PHAR)
Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report released on Friday,Benzinga reports. They presently have a $37.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 321.89% from the stock’s previous close. Separately, Jefferies Financial […]
Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report released on Friday,Benzinga reports. They presently have a $37.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 321.89% from the stock’s previous close. Separately, Jefferies Financial […]
